---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-089940"
form_type: "8-K"
ticker: null
cik: "0001029142"
company_name: "DYNAVAX TECHNOLOGIES CORP"
filed_at: "2024-08-02T23:59:59+00:00"
generated_at: "2026-05-31T13:20:59.192233+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Dynavax reappoints Kelly MacDonald as CFO upon return from maternity leave

## Summary
- Effective August 1, 2024, Board reappointed Kelly MacDonald as CFO (principal financial officer) after maternity leave.
- CEO Ryan Spencer had served as Interim CFO during MacDonald's leave; he now returns solely to CEO role.
- No change in MacDonald's compensation as a result of the reappointment.
- MacDonald's biographical information is referenced from the April 11, 2024 proxy statement.

## SEC filing metadata
- accession: 0000950170-24-089940
- form_type: 8-K
- cik: 0001029142
- company_name: DYNAVAX TECHNOLOGIES CORP
- filed_at: 2024-08-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1029142/000095017024089940/0000950170-24-089940-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1029142/000095017024089940/dvax-20240801.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-089940
- JSON: https://secwatch.observer/filing/0000950170-24-089940.json
- Plain text: https://secwatch.observer/filing/0000950170-24-089940.txt

## Key facts
- Executive change
  Ryan Spencer changed role as Interim Chief Financial Officer at DYNAVAX TECHNOLOGIES CORP.
  - Action: ceased serving as Interim CFO
  - Role: Interim Chief Financial Officer
  source text: Upon Ms. MacDonald's return, Mr. Spencer will no longer serve as Interim CFO but continues as CEO.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1029142/000095017024089940/0000950170-24-089940-index.htm
- Executive change
  Kelly MacDonald was appointed as Chief Financial Officer at DYNAVAX TECHNOLOGIES CORP.
  - Action: re-appointed
  - Role: Chief Financial Officer
  source text: Effective August 1, 2024, the Board of Directors of Dynavax Technologies Corporation (the “Company”) re-appointed Kelly MacDonald to serve as the Company’s Chief Financial Officer (principal financial officer) upon her return from maternity leave.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1029142/000095017024089940/0000950170-24-089940-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.